Is a hematocrit of 36.8% normal for a pregnant woman, and does it require treatment?

A hematocrit of 36.8% in pregnancy is normal and does not require treatment.

Understanding Normal Hematocrit in Pregnancy

This hematocrit value falls well above the threshold for anemia in pregnancy and represents physiologic hemodilution, not pathology. During pregnancy, plasma volume expands disproportionately to red blood cell mass, causing a normal decrease in hematocrit—this is an expected and healthy adaptation 1.

Defining Anemia in Pregnancy

According to current guidelines, anemia in pregnancy is defined as 2, 3:

• First trimester: Hemoglobin <11.0 g/dL (hematocrit <33%)
• Second trimester: Hemoglobin <10.5 g/dL (hematocrit <31.5%)
• Third trimester: Hemoglobin <10.5-11.0 g/dL (hematocrit <31.5-33%)

A hematocrit of 36.8% is approximately 4-5 percentage points above the anemia threshold, placing this patient in the normal range regardless of trimester.

Evidence-Based Reference Values

Contemporary research from a large multiethnic cohort established that the fifth percentile (lower limit of normal) for hematocrit in low-risk pregnancies is 1:

• First trimester: 32.8%
• Second trimester: 30.2%
• Third trimester: 30.6%

Your patient's hematocrit of 36.8% exceeds even these conservative lower limits by a substantial margin.

Treatment Recommendations

No treatment is indicated. The evidence shows 2:

• The USPSTF found insufficient evidence to recommend routine iron supplementation in non-anemic pregnant women
• While routine prenatal vitamins containing 30 mg elemental iron are standard practice, therapeutic iron supplementation (60-120 mg daily) is reserved for documented iron deficiency anemia
• Treatment of non-anemic women has not been shown to improve maternal or fetal outcomes

Clinical Pitfalls to Avoid

Do not over-treat physiologic hemodilution. Common mistakes include:

1. Misinterpreting normal pregnancy-related hematocrit decline as pathology: The expected drop in hematocrit during pregnancy is physiologic and beneficial for placental perfusion
2. Applying non-pregnant reference ranges: Using standard laboratory reference ranges (typically 36-46% for women) will incorrectly flag normal pregnant women as anemic
3. Unnecessary iron supplementation: High-dose iron in non-anemic women causes gastrointestinal side effects without proven benefit 2

When to Reassess

Continue routine prenatal screening as recommended 2, 3:

• Recheck complete blood count at 24-28 weeks gestation
• If hematocrit remains >33% (hemoglobin >11 g/dL), no intervention needed
• Consider treatment only if hematocrit falls below 30% (hemoglobin <10 g/dL)

Research demonstrates that women with initial hematocrit >39% rarely develop anemia requiring intervention 4, and your patient at 36.8% has adequate reserve.

Racial Considerations

Be aware that African and Asian women have physiologically lower hemoglobin and hematocrit values (approximately 0.7% lower hematocrit) compared to Caucasian women, even in healthy pregnancy 1, 5. This represents normal variation, not pathology requiring treatment.